BIOCRYST PHARMACEUTICALS, INC. Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax of $244.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax · last filed 2018-03-12
- 2017-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $244.00K.
- 2017-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $21.00K.
- 2017-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $25.00K.
- 2017-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $14.00K.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax as first filed |
|---|---|---|
| 2017-12-31 | $244.00K 10-K · filed 2018-03-12 | |
| 2017-09-30 | $21.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $25.00K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $14.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $23.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $5.00K 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $8.00K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $17.00K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $212.00K 10-K · filed 2017-02-27 | |
| 2015-09-30 | -$65.00K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | -$111.00K 10-Q · filed 2015-08-07 | |
| 2014-12-31 | $133.00K 10-K · filed 2016-02-26 | -$133.00K 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |